FIBROBIOLOGICS INC (FBLG)

US31573L1052 - Common Stock

1.985  -0.01 (-0.75%)

After market: 1.99 +0 (+0.25%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
N/AN/AN/AN/AN/AN/A
235.70%		N/A
292.40%		N/A
122.89%
EBITDA
YoY % growth
N/AN/A-8.842MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
-1.578M-4.467M
-183.08%		-8.889M
-98.99%		N/A
-53.14%		N/A
-15.86%		N/A
-48.46%		N/A
-54.22%		N/A
-8.86%		N/A
32.45%		N/A
316.28%		N/A
253.06%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/A
-8.09%		N/A
-31.29%		N/A
15.03%		N/A
-19.51%		N/A
6.12%		N/A
202.17%		N/A
419.15%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth		-0.09
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-3.393M
-36.81%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.01 -0.090.0888.69%
Q2 2024
Q2Q % growth		 -0.02 -0.090.0778.21%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 5.56% 15%
RevenueN/A N/A N/A N/A